Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement

Corporate Breaking News

Home : Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement

Oct 07 2020	Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement
MADISON, Wis. and NEW YORK, Oct. 7, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) and Pfizer Inc. (NYSE: PFE) today announced an extension and amendment of their agreement to promote Cologuard, the first and only FDA-approved non-invasive stool DNA screening test for colorectal...


Source:https://www.prnewswire.com:443/news-releases/exact-sciences-and-pfizer-extend-and-amend-cologuard-promotion-agreement-301147497.html

Related News
» The Global Bio-succinic Acid Market is expected to grow by USD 1.67 bn during 2020-2024, progressing at a CAGR of 25% during the forecast period » ClimateCheck Launches First Property Level Assessments of Climate Change Driven Wildfire Impacts on Homes, Land